Cryoballoon Ablation System Market Outlook (2023 to 2033)

The global cryoballoon ablation system market is estimated to be valued at US$ 1.1 billion in 2023 and is likely to surpass US$ 1.8 billion by 2033. The demand for cryoballoon ablation systems is projected to record a CAGR of 4.9% during the forecast period.

Key Market Highlights:

  • In recent years, rising cardiac or heart-related problems in medical establishments have boosted the adoption of cryoballoon ablation systems.
  • A better solution evolved for treating this disease through the invention is likely to propel the cryoballoon ablation system market growth during the forecast period.
  • Hospitals and research institutes are the prominent end-use industries that have accelerated the cryoballoon ablation system market share.

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

Key Factors in the Cryoballoon Ablation System Market

Due to rising heart attacks, dementia, and death, the adoption of cryoballoon ablation systems is likely to increase worldwide to treat these diseases. However, a desire to lead a stress-free, healthy mental and social life also increases the demand for such products in the market. Using a cryoballoon ablation system can also reduce the duration and severity of the post-treatment traumatic pains after the treatment.

Manufacturing companies are also putting forth much effort in the segment where new technologies are being introduced. Furthermore, increasing the interest of investors and encouraging them to invest in this segment more actively also drives the cryoballoon ablation system market growth.

Continuous lesions around the ostium provided by the cryoballoon ablation system are also one of the key driving factors of the market.

Growth Restraining Factors in the Cryoballoon Ablation System Market

The cryoballoon ablation system is gaining popularity, but the general public still needs to know its applications and benefits. As a result, the market needed to grow smoothly for an extended period before gaining the proper level of awareness to grow steadily. In addition to the lack of flexibility in the cryoballoon ablation system, the market is likely to encounter severe obstacles shortly. Conversely, cryoballoon ablation systems might also be limited in their growth by their rigidity, which can result in incomplete vein occlusion and inconsistent electrogram recording.

Researchers are constantly updating the technologies used in this system. However, it is a lengthy process that requires time and patience. Hence, continuous successful advancements are necessary for the market to remain the same.

Attributes Details
Market CAGR (2023 to 2033) 4.9%
Market Valuation (2023) US$ 1.1 billion
Market Valuation (2033) US$ 1.8 billion
Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

2018 to 2022 Cryoballoon Ablation System Market Outlook Compared to 2023 to 2033 Forecast

The global market secured a valuation of US$ 1.06 billion in 2022 with a CAGR of 3.8%. The demand for cryoballoon ablation systems is increasing due to cardiac patients and treatment procedures. Growing healthcare provider's awareness and adoption of advanced technologies playing a crucial role in improving patients' health are driving the global market.

Healthcare professionals increase the adoption of cryoballoon ablation systems for effective treatment with real-time monitoring integration. They are ensuring safe and efficient procedures compared to traditional ones to reduce risk and recover patients' health conditions.

Segment Insights

Hospital Segment Dominates the Cryoballoon Ablation System Market

Based on end-user type, the hospital segment dominates the market during the forecast period. Globally, the growing aging population and poor eating habits of young people have led to increased heart disease. Therefore, growth in surgeries increase the demand for cryoballoon ablation systems in hospitals. The hospital sector is anticipated to register a share of 48.1% in the global market by 2033.

Incorporating sophisticated infrastructure and advanced technologies into healthcare facilities has enhanced healthcare quality. By increasing patient inflow in the settings for ablation therapy, the network of hospitals across various countries increases accessibility to advanced treatments.

In both developing and developed countries, hospitals are expanding their networks to increase access to treatment. Consequently, hospitals aim to increase the availability of technology to help meet the needs of the enormous patient.

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

Regional Insights

Countries Forecast Share
United States 34.4%
Germany 9.0%
Japan 4.6%
Countries Forecast CAGR
Australia 4.1%
China 6.0%
India 6.7%
United Kingdom 3.6%

North America Cryoballoon Ablation System Market Outlook

The market is segmented geographically into North America, Europe, Latin America, Asia Pacific, the Middle East, and Africa. North America dominates the market by securing 41.2% of the share during the forecast period. Rising cardiac arrests and stroke deaths are the primary reason for the cryoballoon ablation system market growth. The United States is leading the market due to adopting unhealthy lifestyles and casual food habits, with a share of 34.4% by 2033.

Innovations in the healthcare sector are a prominent factor in growing the market continuously in North America. According to the Centers for Disease Control and Prevention, each year, America’s death rate crosses nearly 6.5 million from cardiovascular diseases. Moreover, the availability of advanced treatment options and raising awareness about cardiovascular diseases are likely to drive the market's growth.

A cryoablation catheter system designed to treat drug-refractory paroxysmal atrial fibrillation (A.F.) has been approved by the FDA in the United States. This technology provides a straightforward and efficient way to isolate pulmonary veins and allows patients to receive a minimally invasive, safe, and effective treatment for atrial fibrillation.

A Deep View of the European Cryoballoon Ablation System Market Size

North America follows Europe to secure a higher share in the cryoballoon ablation system market by acquiring 28.7% of the claim during the forecast period. With rising, government initiatives and medical treatments have grown in the market in recent years. Moreover, technological advancement and research & development stimulate the demand for cryoballoon ablation systems.

At the Royal Papworth Hospital, a new generation of cryo balloons is being used to speed up treatment for patients with atrial fibrillation (A.F.). One million people in the United Kingdom suffer from A.F., which is treated through ablation. Moreover, it is expected that rising consumer preference for minimally invasive, effective, and painless surgical treatments are anticipated to drive the demand for cryoballoon ablation system in the future.

Healthcare facilities are increasingly adopting advanced technology-enabled devices along with sophisticated infrastructure, which positively impacts the success rate of medical procedures.

Competitive Landscape

These critical cryoballoon ablation system providers are employing several strategies to improve sales and gain a competitive edge in the global cryoballoon ablation system market, including new product launches and approvals, partnerships, collaborations, acquisitions, mergers, etc. For instance,

  • In June 2022, Boston Scientific Inc. planned to raise the amount of its investment to an additional US$ 62.5 million in Alpharetta-based EndoChoice Inc. Building a new plant near the existing one allows the company to hire more employees and include more medical devices. In addition to introducing new devices, Boston Scientific may also teach advanced technologies into its processes. As a result, the company could sustain itself in the market.
  • In July 2022, Boston Scientific also gained a majority stake in their partnership with M.I. Tech at US$ 230 million. This partnership may help Boston Scientific to enter a new market with firm support. It further helps the company to achieve recent technological advancements in its usage of medical devices.

Some Leading Cryoballoon Ablation System Device Manufacturers include

  • Synmed. CO.United Kingdom
  • Pentax Medical
  • Medtronic
  • CPSI BIOTECH
  • Healthtronics, Inc.
  • Atricure, Inc.
  • Adagio Medical
  • Coopersurgical Inc.
  • SANARUS TECHNOLOGIES
  • Boston Scientific Corporation
  • BVM Medical Limited
  • Secure Medical
  • Galil Medical Inc.
  • Biosense Webster

Scope of Report

Attribute Details
Forecast Period 2023 to 2033
Historical Data Available for 2018 to 2022
Market Analysis US$ billion for Value
Key Countries Covered United States, United Kingdom, Japan, India, China, Australia, Germany
Key Segments Covered Region, End Use
Key Companies Profiled Synmed.CO.UK; Pentax Medical; Medtronic; CPSI BIOTECH; Healthtronics, Inc.; Atricure, Inc.; Adagio Medical; Coopersurgical Inc.; SANARUS TECHNOLOGIES; Boston Scientific Corporation; BVM Medical Limited; Secure Medical; Galil Medical Inc.; Biosense Webster
Report Coverage Market Forecast, Company Share Analysis, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, and Strategic Growth Initiatives
Customization & Pricing Available upon Request

Cryoballoon Ablation System Market by Segmentation

By End Users:

  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers

By Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • The Middle East & Africa (MEA)

Frequently Asked Questions

How Big is the Cryoballoon Ablation System market?

The market is valued at US$ 1.1 billion in 2023.

Who are the key Cryoballoon Ablation System Players?

Pentax Medical, Medtronic, CPSI BIOTECH are key market players.

What is the growth forecast for Cryoballoon Ablation System Market?

The market is forecast to register a CAGR of 4.9% through 2033.

What will the market size be in 2033?

The market will reach US$ 1.8 billion by 2033.

Which region will dominate the market in forecast period?

North America will dominate the market during the forecast period.

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand-side Trends

    1.3. Supply-side Trends

    1.4. Technology Roadmap Analysis

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Background

    3.1. Market Dynamics

        3.1.1. Drivers

        3.1.2. Restraints

        3.1.3. Opportunity

        3.1.4. Trends

    3.2. Scenario Forecast

        3.2.1. Demand in Optimistic Scenario

        3.2.2. Demand in Likely Scenario

        3.2.3. Demand in Conservative Scenario

    3.3. Opportunity Map Analysis

    3.4. Investment Feasibility Matrix

    3.5. PESTLE and Porter’s Analysis

    3.6. Regulatory Landscape

        3.6.1. By Key Regions

        3.6.2. By Key Countries

    3.7. Regional Parent Market Outlook

4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033

    4.1. Historical Market Size Value (US$ Million) Analysis, 2018 to 2022

    4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033

        4.2.1. Y-o-Y Growth Trend Analysis

        4.2.2. Absolute $ Opportunity Analysis

5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End Users

    5.1. Introduction / Key Findings

    5.2. Historical Market Size Value (US$ Million) Analysis By End Users, 2018 to 2022

    5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End Users, 2023 to 2033

        5.3.1. HospitalsTest

        5.3.2. Hospitals

        5.3.3. Clinics

        5.3.4. Ambulatory Surgical Centers

    5.4. Y-o-Y Growth Trend Analysis By End Users, 2018 to 2022

    5.5. Absolute $ Opportunity Analysis By End Users, 2023 to 2033

6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region

    6.1. Introduction

    6.2. Historical Market Size Value (US$ Million) Analysis By Region, 2018 to 2022

    6.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033

        6.3.1. North America

        6.3.2. Latin America

        6.3.3. Western Europe

        6.3.4. Eastern Europe

        6.3.5. South Asia and Pacific

        6.3.6. East Asia

        6.3.7. Middle East and Africa

    6.4. Market Attractiveness Analysis By Region

7. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    7.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    7.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        7.2.1. By Country

            7.2.1.1. USA

            7.2.1.2. Canada

        7.2.2. By End Users

    7.3. Market Attractiveness Analysis

        7.3.1. By Country

        7.3.2. By End Users

    7.4. Key Takeaways

8. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    8.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    8.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        8.2.1. By Country

            8.2.1.1. Brazil

            8.2.1.2. Mexico

            8.2.1.3. Rest of Latin America

        8.2.2. By End Users

    8.3. Market Attractiveness Analysis

        8.3.1. By Country

        8.3.2. By End Users

    8.4. Key Takeaways

9. Western Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        9.2.1. By Country

            9.2.1.1. Germany

            9.2.1.2. UK

            9.2.1.3. France

            9.2.1.4. Spain

            9.2.1.5. Italy

            9.2.1.6. Rest of Western Europe

        9.2.2. By End Users

    9.3. Market Attractiveness Analysis

        9.3.1. By Country

        9.3.2. By End Users

    9.4. Key Takeaways

10. Eastern Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        10.2.1. By Country

            10.2.1.1. Poland

            10.2.1.2. Russia

            10.2.1.3. Czech Republic

            10.2.1.4. Romania

            10.2.1.5. Rest of Eastern Europe

        10.2.2. By End Users

    10.3. Market Attractiveness Analysis

        10.3.1. By Country

        10.3.2. By End Users

    10.4. Key Takeaways

11. South Asia and Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        11.2.1. By Country

            11.2.1.1. India

            11.2.1.2. Bangladesh

            11.2.1.3. Australia

            11.2.1.4. New Zealand

            11.2.1.5. Rest of South Asia and Pacific

        11.2.2. By End Users

    11.3. Market Attractiveness Analysis

        11.3.1. By Country

        11.3.2. By End Users

    11.4. Key Takeaways

12. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        12.2.1. By Country

            12.2.1.1. China

            12.2.1.2. Japan

            12.2.1.3. South Korea

        12.2.2. By End Users

    12.3. Market Attractiveness Analysis

        12.3.1. By Country

        12.3.2. By End Users

    12.4. Key Takeaways

13. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        13.2.1. By Country

            13.2.1.1. GCC Countries

            13.2.1.2. South Africa

            13.2.1.3. Israel

            13.2.1.4. Rest of MEA

        13.2.2. By End Users

    13.3. Market Attractiveness Analysis

        13.3.1. By Country

        13.3.2. By End Users

    13.4. Key Takeaways

14. Key Countries Market Analysis

    14.1. USA

        14.1.1. Pricing Analysis

        14.1.2. Market Share Analysis, 2022

            14.1.2.1. By End Users

    14.2. Canada

        14.2.1. Pricing Analysis

        14.2.2. Market Share Analysis, 2022

            14.2.2.1. By End Users

    14.3. Brazil

        14.3.1. Pricing Analysis

        14.3.2. Market Share Analysis, 2022

            14.3.2.1. By End Users

    14.4. Mexico

        14.4.1. Pricing Analysis

        14.4.2. Market Share Analysis, 2022

            14.4.2.1. By End Users

    14.5. Germany

        14.5.1. Pricing Analysis

        14.5.2. Market Share Analysis, 2022

            14.5.2.1. By End Users

    14.6. UK

        14.6.1. Pricing Analysis

        14.6.2. Market Share Analysis, 2022

            14.6.2.1. By End Users

    14.7. France

        14.7.1. Pricing Analysis

        14.7.2. Market Share Analysis, 2022

            14.7.2.1. By End Users

    14.8. Spain

        14.8.1. Pricing Analysis

        14.8.2. Market Share Analysis, 2022

            14.8.2.1. By End Users

    14.9. Italy

        14.9.1. Pricing Analysis

        14.9.2. Market Share Analysis, 2022

            14.9.2.1. By End Users

    14.10. Poland

        14.10.1. Pricing Analysis

        14.10.2. Market Share Analysis, 2022

            14.10.2.1. By End Users

    14.11. Russia

        14.11.1. Pricing Analysis

        14.11.2. Market Share Analysis, 2022

            14.11.2.1. By End Users

    14.12. Czech Republic

        14.12.1. Pricing Analysis

        14.12.2. Market Share Analysis, 2022

            14.12.2.1. By End Users

    14.13. Romania

        14.13.1. Pricing Analysis

        14.13.2. Market Share Analysis, 2022

            14.13.2.1. By End Users

    14.14. India

        14.14.1. Pricing Analysis

        14.14.2. Market Share Analysis, 2022

            14.14.2.1. By End Users

    14.15. Bangladesh

        14.15.1. Pricing Analysis

        14.15.2. Market Share Analysis, 2022

            14.15.2.1. By End Users

    14.16. Australia

        14.16.1. Pricing Analysis

        14.16.2. Market Share Analysis, 2022

            14.16.2.1. By End Users

    14.17. New Zealand

        14.17.1. Pricing Analysis

        14.17.2. Market Share Analysis, 2022

            14.17.2.1. By End Users

    14.18. China

        14.18.1. Pricing Analysis

        14.18.2. Market Share Analysis, 2022

            14.18.2.1. By End Users

    14.19. Japan

        14.19.1. Pricing Analysis

        14.19.2. Market Share Analysis, 2022

            14.19.2.1. By End Users

    14.20. South Korea

        14.20.1. Pricing Analysis

        14.20.2. Market Share Analysis, 2022

            14.20.2.1. By End Users

    14.21. GCC Countries

        14.21.1. Pricing Analysis

        14.21.2. Market Share Analysis, 2022

            14.21.2.1. By End Users

    14.22. South Africa

        14.22.1. Pricing Analysis

        14.22.2. Market Share Analysis, 2022

            14.22.2.1. By End Users

    14.23. Israel

        14.23.1. Pricing Analysis

        14.23.2. Market Share Analysis, 2022

            14.23.2.1. By End Users

15. Market Structure Analysis

    15.1. Competition Dashboard

    15.2. Competition Benchmarking

    15.3. Market Share Analysis of Top Players

        15.3.1. By Regional

        15.3.2. By End Users

16. Competition Analysis

    16.1. Competition Deep Dive

        16.1.1. Synmed.CO.UK

            16.1.1.1. Overview

            16.1.1.2. Product Portfolio

            16.1.1.3. Profitability by Market Segments

            16.1.1.4. Sales Footprint

            16.1.1.5. Strategy Overview

                16.1.1.5.1. Marketing Strategy

        16.1.2. Pentax Medical

            16.1.2.1. Overview

            16.1.2.2. Product Portfolio

            16.1.2.3. Profitability by Market Segments

            16.1.2.4. Sales Footprint

            16.1.2.5. Strategy Overview

                16.1.2.5.1. Marketing Strategy

        16.1.3. Medtronic

            16.1.3.1. Overview

            16.1.3.2. Product Portfolio

            16.1.3.3. Profitability by Market Segments

            16.1.3.4. Sales Footprint

            16.1.3.5. Strategy Overview

                16.1.3.5.1. Marketing Strategy

        16.1.4. CPSI BIOTECH

            16.1.4.1. Overview

            16.1.4.2. Product Portfolio

            16.1.4.3. Profitability by Market Segments

            16.1.4.4. Sales Footprint

            16.1.4.5. Strategy Overview

                16.1.4.5.1. Marketing Strategy

        16.1.5. Healthtronics, Inc.

            16.1.5.1. Overview

            16.1.5.2. Product Portfolio

            16.1.5.3. Profitability by Market Segments

            16.1.5.4. Sales Footprint

            16.1.5.5. Strategy Overview

                16.1.5.5.1. Marketing Strategy

        16.1.6. Atricure, Inc.

            16.1.6.1. Overview

            16.1.6.2. Product Portfolio

            16.1.6.3. Profitability by Market Segments

            16.1.6.4. Sales Footprint

            16.1.6.5. Strategy Overview

                16.1.6.5.1. Marketing Strategy

        16.1.7. Adagio Medical

            16.1.7.1. Overview

            16.1.7.2. Product Portfolio

            16.1.7.3. Profitability by Market Segments

            16.1.7.4. Sales Footprint

            16.1.7.5. Strategy Overview

                16.1.7.5.1. Marketing Strategy

        16.1.8. Coopersurgical Inc.

            16.1.8.1. Overview

            16.1.8.2. Product Portfolio

            16.1.8.3. Profitability by Market Segments

            16.1.8.4. Sales Footprint

            16.1.8.5. Strategy Overview

                16.1.8.5.1. Marketing Strategy

        16.1.9. SANARUS TECHNOLOGIES

            16.1.9.1. Overview

            16.1.9.2. Product Portfolio

            16.1.9.3. Profitability by Market Segments

            16.1.9.4. Sales Footprint

            16.1.9.5. Strategy Overview

                16.1.9.5.1. Marketing Strategy

        16.1.10. Boston Scientific Corporation

            16.1.10.1. Overview

            16.1.10.2. Product Portfolio

            16.1.10.3. Profitability by Market Segments

            16.1.10.4. Sales Footprint

            16.1.10.5. Strategy Overview

                16.1.10.5.1. Marketing Strategy

17. Assumptions & Acronyms Used

18. Research Methodology

Recommendations

Healthcare

Ablation Devices Market

February 2022

REP-GB-11254

January 2023

327 pages

Healthcare

Atrial Fibrillation Device Market

November 2016

REP-GB-2214

May 2022

300 pages

Explore Healthcare Insights

View Reports
Future Market Insights

Cryoballoon Ablation System Market